These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 8411339

  • 21. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
    Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB.
    J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672
    [Abstract] [Full Text] [Related]

  • 22. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC, Woisetschlaeger M, Strominger JL, Speck SH.
    Proc Natl Acad Sci U S A; 1991 Aug 01; 88(15):6550-4. PubMed ID: 1713681
    [Abstract] [Full Text] [Related]

  • 23. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken HJ, Pallesen G.
    Am J Pathol; 1993 Oct 01; 143(4):1072-85. PubMed ID: 8214003
    [Abstract] [Full Text] [Related]

  • 24. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB.
    J Virol; 1992 Dec 01; 66(12):7461-8. PubMed ID: 1331531
    [Abstract] [Full Text] [Related]

  • 25. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
    Finke J, Rowe M, Kallin B, Ernberg I, Rosén A, Dillner J, Klein G.
    J Virol; 1987 Dec 01; 61(12):3870-8. PubMed ID: 2824821
    [Abstract] [Full Text] [Related]

  • 26. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD, Rowe M, Rickinson AB.
    J Gen Virol; 1990 Jul 01; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [Abstract] [Full Text] [Related]

  • 27. Expression of the Epstein-Barr virus (EBV) latent membrane protein is tightly regulated, independently of EB nuclear antigen 2 and of EBV integration or copy number.
    Cordier-Bussat M, Calender A, Vuillaume M, Bornkamm GW, Lenoir GM.
    Virus Res; 1993 Jan 01; 27(1):55-69. PubMed ID: 8383394
    [Abstract] [Full Text] [Related]

  • 28. Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.
    Contreras-Salazar B, Klein G, Masucci MG.
    J Virol; 1989 Jun 01; 63(6):2768-72. PubMed ID: 2542588
    [Abstract] [Full Text] [Related]

  • 29. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
    Brooks L, Yao QY, Rickinson AB, Young LS.
    J Virol; 1992 May 01; 66(5):2689-97. PubMed ID: 1313894
    [Abstract] [Full Text] [Related]

  • 30. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.
    Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB.
    J Virol; 1992 Jan 01; 66(1):122-31. PubMed ID: 1309242
    [Abstract] [Full Text] [Related]

  • 31. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
    Evans TJ, Jacquemin MG, Farrell PJ.
    Virology; 1995 Feb 01; 206(2):866-77. PubMed ID: 7856099
    [Abstract] [Full Text] [Related]

  • 32. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    Rooney C, Howe JG, Speck SH, Miller G.
    J Virol; 1989 Apr 01; 63(4):1531-9. PubMed ID: 2538644
    [Abstract] [Full Text] [Related]

  • 33. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG, Iwatsuki K, Oyama N, Ohtsuka M, Satoh M, Kikuchi S, Akiba H, Kaneko F.
    Br J Cancer; 2001 Apr 06; 84(7):920-5. PubMed ID: 11286472
    [Abstract] [Full Text] [Related]

  • 34. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
    McClain K, Estrov Z, Raju U, Kelley PK, Aggarwal BB.
    Methods; 1997 Jan 06; 11(1):83-7. PubMed ID: 8990093
    [Abstract] [Full Text] [Related]

  • 35. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
    Cuomo L, Trivedi P, de Grazia U, Calogero A, D'Onofrio M, Yang W, Frati L, Faggioni A, Rymo L, Ragona G.
    J Med Virol; 1998 Jul 06; 55(3):219-26. PubMed ID: 9624610
    [Abstract] [Full Text] [Related]

  • 36. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
    Schaefer BC, Strominger JL, Speck SH.
    Proc Natl Acad Sci U S A; 1995 Nov 07; 92(23):10565-9. PubMed ID: 7479841
    [Abstract] [Full Text] [Related]

  • 37. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
    Nakagomi H, Dolcetti R, Bejarano MT, Pisa P, Kiessling R, Masucci MG.
    Int J Cancer; 1994 Apr 15; 57(2):240-4. PubMed ID: 8157362
    [Abstract] [Full Text] [Related]

  • 38. Early events in Epstein-Barr virus infection of human B lymphocytes.
    Alfieri C, Birkenbach M, Kieff E.
    Virology; 1991 Apr 15; 181(2):595-608. PubMed ID: 1849678
    [Abstract] [Full Text] [Related]

  • 39. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T.
    Br J Cancer; 1996 Aug 15; 74(4):625-31. PubMed ID: 8761381
    [Abstract] [Full Text] [Related]

  • 40. Partial elimination of Epstein-Barr virus plasmids from Burkitt's lymphoma cells by transfecting the BZLF1 gene.
    Takada K, Ji Z, Fujiwara S, Shimizu N, Tanabe-Tochikura A.
    J Virol; 1992 Sep 15; 66(9):5590-3. PubMed ID: 1323712
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.